MG

Melvin R. Goodes

Board Member at Alzheimer's Drug Discovery Foundation

Melvin R. Goodes joined Warner-Lambert Canada as manager of new product development in 1965 and quickly rose through the ranks to become CEO and Chairman Worldwide in 1991. He helped the pharmaceutical company become a major player in the prescription drug industry by bringing Lipitor to market in 1996. Lipitor had sales of $2.2 billion in 1998 and is one of the largest selling drugs in history.

Mr. Goodes earned his bachelors of commerce degree and was granted an honorary Doctorate of Laws from Queen's University in Kingston, Ontario. He received an MBA from the University of Chicago Booth School of Business, where he was a Ford Foundation and Sears Roebuck fellow. In 2010, Mr. Goodes made headlines with a landmark speech revealing his early-stage Alzheimer's disease and pledging his all to speed the search for new therapies.

Timeline

  • Board Member

    Current role